CAAS Capital Management’s Inozyme Pharma INZY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-113,091
Closed -$771K 481
2021
Q4
$771K Sell
113,091
-22,307
-16% -$152K 0.02% 184
2021
Q3
$1.57M Buy
+135,398
New +$1.57M 0.03% 173
2021
Q2
Sell
-177,502
Closed -$3.52M 821
2021
Q1
$3.52M Buy
+177,502
New +$3.52M 0.04% 201